title: Impaired hepatic handling and processing of lysophosphatidylcholine in rats with liver cirrhosis.
abstract: Lysophosphatidylcholine is a major metabolic product in the plasma and cellular turnover of phospholipids, with well-known membrane-toxic and proinflammatory properties. Because the liver plays a key role in plasma lysophosphatidylcholine removal and biotransformation and because virtually nothing is known of these processes in a diseased organ, the hepatobiliary metabolism of lysophosphatidylcholine was investigated in rats with carbon tetrachloride-induced liver cirrhosis. Twelve adult male Wistar rats with histologically confirmed cirrhosis and 8 control animals were fitted with jugular and biliary catheters and allowed to recover. The animals were kept under constant IV infusion of taurocholate (1 mumol/min). Two microcuries of sn-1[14C]palmitoyl-lysophosphatidylcholine was administered as a single bolus. The fate of the injected radioactivity, including removal from plasma, uptake, and subcellular location in the liver and molecular and aggregative forms, was studied by combined chromatographic and radiochemical methods. Major findings were (a) that lysophosphatidylcholine has a prolonged permanence in plasma of cirrhotic rats, due both to decreased hepatic clearance and to depressed conversion into phosphatidylcholine; (b) that the rate of lysophosphatidylcholine acylation is much slower in the cirrhotic than in the normal liver, both at the microsomal and at the cytosolic level; (c) that cytosolic lysophosphatidylcholine in the cirrhotic liver, but not in the normal liver, is predominantly non-protein bound; (d) that the strict molecular selectivity of lysophosphatidylcholine acylation observed in controls is partially lost in cirrhosis; and (e) that a consistent fraction of lysophosphatidylcholine is converted into triacylglycerols in cirrhotics but not in controls. These findings show a profound derangment of lysophosphatidylcholine handling and processing in the cirrhotic liver, which is of potential pathogenetic significance.
authors.affiliation: II Division of Gastroenterology, University of Rome La Sapienza, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Angelico
authors.forename: D
authors.initials: D
authors.lastname: Alvaro
authors.forename: A
authors.initials: A
authors.lastname: Cantafora
authors.forename: R
authors.initials: R
authors.lastname: Masella
authors.forename: E
authors.initials: E
authors.lastname: Gaudio
authors.forename: C
authors.initials: C
authors.lastname: Gandin
authors.forename: S
authors.initials: S
authors.lastname: Ginanni Corradini
authors.forename: F
authors.initials: F
authors.lastname: Ariosto
authors.forename: O
authors.initials: O
authors.lastname: Riggio
authors.forename: L
authors.initials: L
authors.lastname: Capocaccia
mesh_terms: D008243:1-Acylglycerophosphocholine O-Acyltransferase / Q000378:metabolism; D000818:Animals; D002250:Carbon Radioisotopes; D002251:Carbon Tetrachloride; D003600:Cytosol / Q000201:enzymology; D004195:Disease Models, Animal; D008106:Liver Cirrhosis, Experimental / Q000097:blood / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D008244:Lysophosphatidylcholines / Q000097:blood / Q000378:metabolism*; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
chemical_list: D002250:Carbon Radioisotopes; D008244:Lysophosphatidylcholines; C006065:We 201; D002251:Carbon Tetrachloride; D008243:1-Acylglycerophosphocholine O-Acyltransferase